Hannah Aiken

Veriton Pharma Ltd. engages in the development and manufacture of pharmaceutical products which focuses in the fields of epilepsy, neurology and rare paediatric conditions. It offers Epistatus, paediatric medicine, and inborn errors of metabolism medicine. The company was founded by Graham March in 1997 and is headquartered in Weybridge, the United Kingdom.

Veriton Pharma Ltd. engages in the development and manufacture of pharmaceutical products which focuses in the fields of epilepsy, neurology and rare paediatric conditions. It offers Epistatus, paediatric medicine, and inborn errors of metabolism medicine. The company was founded by Graham March in 1997 and is headquartered in Weybridge, the United Kingdom.

Veriton Pharma Ltd. engages in the development and manufacture of pharmaceutical products which focuses in the fields of epilepsy, neurology and rare paediatric conditions. It offers Epistatus, paediatric medicine, and inborn errors of metabolism medicine. The company was founded by Graham March in 1997 and is headquartered in Weybridge, the United Kingdom.

Veriton Pharma Ltd. engages in the development and manufacture of pharmaceutical products which focuses in the fields of epilepsy, neurology and rare paediatric conditions. It offers Epistatus, paediatric medicine, and inborn errors of metabolism medicine. The company was founded by Graham March in 1997 and is headquartered in Weybridge, the United Kingdom.

Veriton Pharma Ltd. engages in the development and manufacture of pharmaceutical products which focuses in the fields of epilepsy, neurology and rare paediatric conditions. It offers Epistatus, paediatric medicine, and inborn errors of metabolism medicine. The company was founded by Graham March in 1997 and is headquartered in Weybridge, the United Kingdom.